Development of a novel, genome subtraction-derived, sars-cov-2-specific covid-19-nsp2 real-time rt-pcr assay and its evaluation using clinical specimens
Detection Principle
NucleicAcid-PCR based
Target
NSP2-domain
Testing Method Category
Other PCR method(s)
Testing Method
In-house method
Reported Performance
LOD: 1.8 50%-tissue-culture-infective-doses per ml
Sample Size
14 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements